Maven Clinic

We were honored to once again be a sponsor of RESOLVE: The National Infertility Association Night of Hope Gala in New York City, an inspiring evening dedicated to supporting people navigating infertility. This event is always a powerful reminder of the strength and resilience of the family-building community, how far we’ve come in raising awareness and expanding access, and how much more there is still to do together. Grateful to RESOLVE for their continued advocacy and proud to stand alongside them in making fertility care more visible, accessible, and supported for all.

Today is World Prematurity Day. The latest March of Dimes 2025 Report Card paints a stark picture: 👉 The U.S. earned a D+ for its preterm birth rate for the fourth year in a row. 👉 Nearly 1 in 10 babies, or ~380,000 each year, are born too soon. 👉 While 19 states saw improved preterm birth rates, 21 states saw worsened rates. For families, a preterm birth can be an emotionally wrenching experience that often brings unexpected challenges, time away from work, and significant financial strain. Employers feel this impact, too, through increased healthcare costs due to long NICU stays and the challenges families face balancing care and work. At Maven, we know that investing in women's and family health is both the right thing to do and good business. We're helping families catch risks earlier, prevent complications, and recover faster. Just last week, we introduced new features designed to help reduce the risk of preterm birth linked to complications like preeclampsia and gestational diabetes and launched a new NICU program to help families bring their babies home sooner. Every family deserves the chance for a healthy start. Read the full March of Dimes 2025 Report Card, and join us in ensuring every family has the support they need—at home, at work, and every step of the way. https://lnkd.in/e4u6z8-3

This week, we’re celebrating an important milestone in Maven’s mission to improve outcomes for every family. 🎉 Maven just announced the next evolution of our Maternity & Newborn Care Program. We’ve spent more than a decade improving maternity outcomes through proven, evidence-based care. Now, we’re using predictive technology to take that impact even further— with AI-enabled tools that identify risks earlier, evidence-based programs that prevent complications, and expert support that helps families faster. It’s care that’s more predictive, proactive, and proven. Learn how we’re shaping the next era of maternity care ➡️ https://lnkd.in/eMd33CbK

For half a century, women’s bodies have carried the scars of every “miracle” weight-loss breakthrough. GLP-1 drugs, when they arrived, seemed destined to repeat that cycle — until they didn’t. Today one in eight Americans have tried a GLP-1, and most of them are women. And the truth is: they’re working. Metabolic and reproductive health are two sides of the same coin, and it’s against this backdrop that GLP-1 medications may be permanently changing the trajectory of women’s health. In this week’s Preprint, our Chief Medical Officer Neel Shah spoke with four leading obesity specialists: Dr. Fatima Cody Stanford, Dr. Holly Lofton MD, DABOM, Dr. Wendy Vitek, MD, and Dr. Aleesha Grier, Psy.D. about how they’re seeing GLP-1s in the field—and why understanding metabolism is a foundation for fertility, pregnancy, and menopause. ➡️ As a fertility doctor, Dr. Vitek used to have to turn away up to 15% of patients because of the BMI limits associated with egg retrievals. Now, she uses GLP-1s to stabilize metabolic markers before IVF — syncing two biological clocks that, for many women, have long run out of sync. ➡️ Dr. Lofton sees patients across the reproductive lifespan, but in practice many of them are women on reproductive life journeys: trying to get pregnant, trying to lose postpartum weight, or even trying to navigate menopause. Oftentimes she’s the first person to diagnose metabolic dysfunction that hides in plain sight. ➡️ Dr. Grier (who is also a provider on Maven!) has spent her career helping patients navigate weight loss transformations after gastric bypass surgeries. As she says, losing weight is never just weight—it’s also how the world perceives you, and how you perceive the world. It’s not so different from other reproductive journeys. GLP-1s are powerful tools — for everyone, but especially for women. Their impact depends on how medicine uses them: with evidence, oversight, and access. 👉 Read the full Preprint :  https://lnkd.in/gCgMBzHA

For more than a decade, Maven has supported families through every kind of pregnancy — from healthy, routine experiences to more complex, high-risk cases — improving outcomes for families and reducing costs for the employers who support them. Today, we’re taking that impact even further. Our enhanced maternity program builds on what we know works, using the largest validated dataset in digital maternity care to help make care even more predictive, precise, and personalized. With new AI-enabled population health capabilities, Maven helps identify pregnancy risks earlier, prevent and manage complications like preeclampsia and gestational diabetes, and get babies home from the NICU faster. Better care can’t wait. Today, an estimated 15% of pregnancies are considered high-risk, often leading to complications and NICU stays that take a toll on families and represent one of employers’ biggest healthcare costs. Every family deserves to feel safe and supported through pregnancy. These advancements bring us one step closer to making that a reality. Learn more: https://lnkd.in/eucympS3

At Maven, we hear from women every day about the real cost of menopause to their lives: sleepless nights from hot flashes, missed promotions from brain fog, and a body that doesn’t feel like their own. For many of these women, hormone replacement therapy (HRT) is the easiest, safest, and most effective treatment on the market. It restores energy, improves mental clarity, and protects long-term health. And for a long time, this was widely understood—until a landmark study in the 1990s linked HRT to certain cancers and heart disease. In response, the FDA issued a black-box label, and HRT’s reputation has struggled to recover. In the years since, we have learned a lot. Decades of new research have proven HRT’s safety. And while nothing about menopause is one-size-fits-all, HRT is what most often leaves our members telling us they finally “feel like themselves again.” That’s why we’re encouraged to see new FDA actions to remove HRT’s black box warning. It’s more than a policy change, it’s validation for millions of women everywhere. It’s a pivotal step forward, but true impact will come only when every doctor adopts it—and until then, Maven will continue bridging the gap for women everywhere. HRT saves lives. It improves women’s long-term health. We hope this marks the beginning of more research, more funding, more conversation, and more empathy for something all women will undergo eventually.

Labor leaders have always fought for working families and that includes access to quality, affordable care. Maven is proud to partner with unions and trusts to deliver benefits that ensure every member and their family has 24/7 access to high-quality fertility, maternity, and family health care. No waiting, no barriers. With Maven, unions can expand access to care while keeping costs predictable and improving health outcomes for members. Heading to IFEBP’s Annual Conference next week? 👋 Stop by booth #314 to see how Maven is helping labor organizations make family care safer, simpler, and more affordable—and meet our team! Come by to connect with Maven’s own John Corrigan, Christina Packwood, Taryn Murtagh, Sarah Murphy, and Matt Donohue 🤝

Fertility and family-building benefits have quickly become one of the most in-demand offerings for today’s workforce, yet many organizations still struggle to get them right. That’s why we’re excited to introduce the Fertility Benefits Masterclass, a free, expert-led course designed to help HR leaders design smarter fertility benefits with real impact. Whether you're just getting started or looking to optimize your fertility benefits, this course gives you the clarity and confidence to build benefits that deliver across just six short modules. The first module - The Modern Approach to Fertility Care, featuring Neel Shah, Chief Medical Officer at Maven Clinic - is now live. In this first session, you'll learn about the current state of fertility benefits and care, why and how traditional support falls short for employees, and get a preview of what to expect throughout the course. 📝 Start your learning journey at your own pace here: https://lnkd.in/g7axABnA

When Dr. Linda Griffith first started experiencing excruciating pain as a teenager, she was told it was normal. It wasn’t. Years later, after building a career as one of MIT’s leading biomedical engineers, she finally learned what had been wrong all along: stage four endometriosis, a disease that affects millions of women but remains profoundly misunderstood. That diagnosis changed the course of her life — and, ultimately, her field. Dr. Griffith had spent decades designing technologies to understand how the human body repairs itself. But as she confronted her own illness, she realized how little science truly understood about women’s health. So she decided to change that. She founded MIT’s Center for Gynepathology Research, bringing together biologists, engineers, and physicians to study the mechanisms behind endometriosis and menstruation. Her work has since inspired a new generation of researchers — and most recently, a $10 million initiative dedicated to advancing menstruation science. As she reminded us, each cycle the the endometrium sheds and then regenerates. "It’s an incredible example of scarless healing in most healthy women, and it’s all tightly regulated by hormones," she said. Dr. Griffith’s story is one of personal pain turned into purpose. It’s also a reminder of how much progress depends on people who refuse to accept “this is just how it is.” 📚You can read the full conversation in this week’s Preprint: https://lnkd.in/gSQSBaBn